Showing results (741-750 of 772) with videos related to
Sort By:
Pageof 78
Journal of Biomolecular Screening|August 21, 2012
Development and validation of reagents and assays for EZH2 peptide and nucleosome high-throughput screensElsie Diaz, Carl A Machutta, Stephanie Chen, et al.Emerging Microbes & Infections|August 31, 2023
Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigenJoseph Jelinski, Monika M Kowatsch, Marc-Alexandre Lafrance, et al.Nature|October 12, 2012
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T McCabe, Heidi M Ott, Gopinath Ganji, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridinesHong Lin, Dennis S Yamashita, Ren Xie, et al.Journal of Eating Disorders|February 6, 2020
Canadian practice guidelines for the treatment of children and adolescents with eating disordersJennifer Couturier, Leanna Isserlin, Mark Norris, et al.Vaccines|April 27, 2024
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus MacaquesAlice Berger, Jannie Pedersen, Monika M Kowatsch, et al.Plos Biology|November 2, 2017
Uncovering protein-protein interactions through a team-based undergraduate biochemistry courseDavid L Cookmeyer, Emily S Winesett, Bashkim Kokona, et al.Journal of Eating Disorders|April 17, 2021
The COVID-19 pandemic and eating disorders in children, adolescents, and emerging adults: virtual care recommendations from the Canadian consensus panel during COVID-19 and beyondJennifer Couturier, Danielle Pellegrini, Catherine Miller, et al.Oncoimmunology|December 15, 2018
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trialsJonathan G Pol, Sergio A Acuna, Beta Yadollahi, et al.Journal of Medicinal Chemistry|February 18, 2005
Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cellsBruce L Grasberger, Tianbao Lu, Carsten Schubert, et al.Pageof 78